Emergency authorisation sought for coronavirus vaccines by Pfizer and Oxford-AstraZeneca in India – ABC News

Emergency authorisation has been sought for the use of Pfizer and Oxford-AstraZeneca’s coronavirus vaccines in India, following the lead of the UK and Russia.
Key points:

• India has reported the second-highest number of coronavirus cases in the world
• The chief executive of one of the world’s largest vaccine producers said approval would “save countless lives”
• Experts say distribution of Pfizer’s vaccine may be difficult in India because it needs to be kept below -70 degrees Celsius

The Serum Institute…

Click here to view the original article.